Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on August 19, 2025
Armored Ambulance Market to Reach USD $1.62 Billion by 2029 at 7.1% CAGR
The Business Research Company's Armored Ambulance Market to Reach USD $1.62 Billion by 2029 at 7.1% CAGR LONDON, GREATER LONDON, UNITED KINGDOM, August 20, 2025 /EINPresswire.com/ -- "Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead …
Autonomous Naval Vessel Market Anticipated to Grow at 8.9% CAGR Through 2029: Industry Report
The Business Research Company's Autonomous Naval Vessel Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 20, 2025 /EINPresswire.com/ -- What Is The Autonomous Naval Vessel …
Bulletproof Helmet Market Projected to Reach $1.5 Billion with 6.6% CAGR by 2029
The Business Research Company’s Bulletproof Helmet Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 20, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Bulletproof Helmet …
CORRECTION – Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
IRVINE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that addresses unmet clinical needs, announced today corrections to the second paragraph of its …
Neonatal and Pediatric Hospitalist Dr. Gabriella Dauer Shares Her Top Tips for Beating Back-to-School Bugs on YourUpdateTV
From hygiene habits to trusted remedies like Mucinex, learn why early prevention is key as kids head back to school NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Backpacks, new shoes, and fresh routines mark the start of a new school year—but it’s also prime …
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
EMERYVILLE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a $6 million securities purchase agreement with private investor David E. Lazar for the …
Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025
TORBAL DIVISION SALES UP 11% SECURED $10 MILLION IN STRATEGIC DIVESTURE OF GENIE PRODUCT LINE VIVID AND BIOPROCESSING NEW PRODUCT AI ROADMAP ON TARGET Investor Call to be held Wednesday, August 20th at 11:00 a.m. Eastern Time BOHEMIA, N.Y., Aug. 19, 2025 ( …
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos’ differentiated array of highly effective OSA treatments Management to Host Conference Call today at 5:00 pm ET …
Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock
Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced that its Board of Directors has approved …
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO-NASH trial demonstrating Rezdiffra reduced fibrosis, …
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)
Study met primary endpoint demonstrating barzolvolimab’s ability to potently deplete mast cells in the gastrointestinal tract Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a …
Arcutis to Present at Upcoming Investor Conferences
WESTLAKE VILLAGE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis …
Ligand to Participate in September Investor Conferences
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor …
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15, 2025 it granted stock options to purchase an aggregate of 105,169 shares of common stock and 70,879 restricted stock …
NMDP Announces Nationwide Celebration and Fundraiser to Help Patients in Need of Life-Saving Cell Therapy
MINNEAPOLIS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- NMDP℠ (formerly Be The Match®), a global nonprofit leader in cell therapy, invites communities nationwide to join NMDP Unite: a community celebration to find cures and save lives. This free, family-friendly …
REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer …
Fayetteville State University Shows Research Muscle in Soy Genetics
Fayetteville, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Breeders may soon have a better approach to grow soybeans with more of a health-promoting peptide. In a new peer-reviewed study supported by the National Science Foundation, Fayetteville State …
Epione Beverly Hills Releases Landmark Study Led by Dr. Simon Ourian Confirming Long-Term Effectiveness of Non-Surgical Under-Eye Dark Circle Treatment
Beverly Hills, CA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Epione Beverly Hills, a leader in non-invasive aesthetic treatments, announced today the results of a landmark four-year retrospective study evaluating its proprietary Coolaser® and Neustem™ technology …
Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030
Boston, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Tissue Engineering and Regeneration: Technologies and Global Markets” is estimated to increase from $5.4 billion in 2025 to $9.8 billion by the end of 2030, at …
Why Healthletic's First-Day Colostrum Is Revolutionizing Whole-Body Wellness: The Science Behind Nature's Original Superfood
New York, Aug. 19, 2025 (GLOBE NEWSWIRE) -- In an era where wellness enthusiasts chase the latest biohacking trends and superfood supplements, a growing number of health-conscious individuals are turning to one of nature's oldest nutritional powerhouses: …